Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. (Q37782148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

B van Zaane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

E Nur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Squizzato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

V E A Gerdes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H R Büller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

D P M Brandjes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

2483-2493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20735729%20AND%20SRC:MED&resulttype=core&format=json

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Use of oral corticosteroids in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

High-Dose Corticosteroid Treatment Is Associated with an Increased Risk of Developing Cerebral Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Hypercoagulable state in Cushing's syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

New methods in coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

How depression may increase cardiac risk: effect of hypercortisolism on platelet activation markers: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Platelet count and function at high altitude and in high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Glucocorticoids and insulin sensitivity: dissociation of insulin's metabolic and vascular actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Dexamethasone effect on prostanoid formation in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Plasma viscosity in giant cell arteritis as a predictor of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Impaired activation of the fibrinolytic system in children with Henoch-Schönlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

von Willebrand factor, endothelial dysfunction, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Bidirectional relation between inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Effect of high-dose corticosteroids on the incidence of deep vein thrombosis after total hip replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04034.X